Login / Signup

Meet in the middle: Could cell mediated-immunity assays be the answer for ideal Cytomegalovirus prophylaxis after lung transplantation? Observational study from a single center with intermittent antiviral prophylaxis.

Silvia Vidal CamposLisete Ribeiro TeixeiraMaristela Pinnheiro FreireAna Carolina MamanaClarisse Martins Machado
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2023)
QuantiFERON-CMV may be another diagnostic tool to help stratify CMV-disease risk and individualized antiviral prophylaxis after LTx.
Keyphrases
  • single cell
  • high throughput
  • epstein barr virus
  • cell therapy
  • stem cells